Product Code: ETC6186405 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The non-vascular stents market in Australia is expanding due to increased demand for minimally invasive procedures to treat obstructive conditions in the gastrointestinal, urological, and pulmonary systems. Non-vascular stents are widely used for relieving obstructions in the bile duct, esophagus, colon, and trachea. Growing cases of gastrointestinal cancers, benign strictures, and respiratory complications are driving market demand. Advancements in stent design, including the use of bioresorbable materials and drug-eluting coatings, are enhancing patient outcomes and reducing complications. Increased awareness about non-invasive treatment options and favorable reimbursement policies are supporting market growth. Additionally, the rise in the aging population and increasing prevalence of chronic diseases are contributing to the growing adoption of non-vascular stents in healthcare facilities across Australia.
The non-vascular stents market in Australia is driven by increasing cases of urinary tract and gastrointestinal obstructions. Growing adoption of ureteral, biliary, and pancreatic stents, increasing availability of minimally invasive treatment options, and rising focus on improving patient outcomes are fueling market growth. Expanding use of biodegradable and drug-eluting stents is also contributing to market expansion.
The non-vascular stents market in Australia faces challenges from high product development costs and stringent regulatory requirements. Limited availability of advanced stent technology and high procedural costs reduce market penetration. Competition from vascular stents and alternative surgical treatments reduces market demand. Concerns about product durability and long-term clinical outcomes further restrict market adoption.
The non-vascular stents market in Australia is growing due to increasing demand for stents used in non-cardiovascular applications, such as urology, gastroenterology, and pulmonology. Non-vascular stents are used to treat obstructions in the urinary tract, bile duct, esophagus, and airway. Investment opportunities exist in developing bioabsorbable and drug-eluting stents, improving stent delivery systems, and expanding product availability through public and private healthcare channels. Growth in chronic disease cases and increasing preference for minimally invasive procedures are driving market demand.
Non-vascular stents, including urological, gastrointestinal, and airway stents, are regulated by the TGA to ensure they meet safety and clinical performance standards. The Pharmaceutical Benefits Scheme (PBS) subsidizes the cost of non-vascular stent implantation for eligible patients, improving access to treatment. The government funds clinical research through the National Health and Medical Research Council (NHMRC) to develop advanced stent materials, such as bioresorbable and drug-eluting stents. Public hospitals and healthcare facilities receive government funding to upgrade medical infrastructure for stent implantation procedures. The government also promotes minimally invasive techniques for stent placement through training programs and public health initiatives aimed at improving patient outcomes.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Non-vascular Stents Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Non-vascular Stents Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Non-vascular Stents Market - Industry Life Cycle |
3.4 Australia Non-vascular Stents Market - Porter's Five Forces |
3.5 Australia Non-vascular Stents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Non-vascular Stents Market Revenues & Volume Share, By Material, 2021 & 2031F |
3.7 Australia Non-vascular Stents Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Australia Non-vascular Stents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Non-vascular Stents Market Trends |
6 Australia Non-vascular Stents Market, By Types |
6.1 Australia Non-vascular Stents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Non-vascular Stents Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia Non-vascular Stents Market Revenues & Volume, By Pulmonology Stents, 2021- 2031F |
6.1.4 Australia Non-vascular Stents Market Revenues & Volume, By Urology Stents, 2021- 2031F |
6.1.5 Australia Non-vascular Stents Market Revenues & Volume, By Gastroenterology Stents, 2021- 2031F |
6.1.6 Australia Non-vascular Stents Market Revenues & Volume, By Enteral Stents, 2021- 2031F |
6.1.7 Australia Non-vascular Stents Market Revenues & Volume, By Biliary and Pancreatic Stents, 2021- 2031F |
6.2 Australia Non-vascular Stents Market, By Material |
6.2.1 Overview and Analysis |
6.2.2 Australia Non-vascular Stents Market Revenues & Volume, By Metallic Stents, 2021- 2031F |
6.2.3 Australia Non-vascular Stents Market Revenues & Volume, By Non-metallic Stents, 2021- 2031F |
6.3 Australia Non-vascular Stents Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Australia Non-vascular Stents Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Non-vascular Stents Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 Australia Non-vascular Stents Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Non-vascular Stents Market Import-Export Trade Statistics |
7.1 Australia Non-vascular Stents Market Export to Major Countries |
7.2 Australia Non-vascular Stents Market Imports from Major Countries |
8 Australia Non-vascular Stents Market Key Performance Indicators |
9 Australia Non-vascular Stents Market - Opportunity Assessment |
9.1 Australia Non-vascular Stents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Non-vascular Stents Market Opportunity Assessment, By Material, 2021 & 2031F |
9.3 Australia Non-vascular Stents Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Australia Non-vascular Stents Market - Competitive Landscape |
10.1 Australia Non-vascular Stents Market Revenue Share, By Companies, 2024 |
10.2 Australia Non-vascular Stents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |